Cargando…

Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review

The first choice drugs for the treatment of cutaneous and mucocutaneous leishmaniasis are pentavalent antimonials, sodium stibogluconate, or meglumine antimoniate. However, the treatment with these drugs is expensive, can cause serious adverse effects, and is not always effective. The combination of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berbert, Taisa Rocha Navasconi, de Mello, Tatiane França Perles, Wolf Nassif, Priscila, Mota, Camila Alves, Silveira, Aline Verzignassi, Duarte, Giovana Chiqueto, Demarchi, Izabel Galhardo, Aristides, Sandra Mara Alessi, Lonardoni, Maria Valdrinez Campana, Vieira Teixeira, Jorge Juarez, Silveira, Thaís Gomes Verziganassi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323433/ https://www.ncbi.nlm.nih.gov/pubmed/30675152 http://dx.doi.org/10.1155/2018/9014726

Ejemplares similares

Antileishmanial activity of the essential oil from Tetradenia riparia obtained in different seasons
por: Cardoso, Bruna Muller, et al.
Publicado: (2015)

Filter paper performance in PCR for cutaneous leishmaniasis diagnosis
por: Mota, Camila Alves, et al.
Publicado: (2020)

Diagnostic methods to cutaneous leishmaniasis detection in domestic dogs and cats
por: Trevisan, Daliah Alves Coelho, et al.
Publicado: (2015)

NEW PRIMERS FOR DETECTION OF Leishmania infantumUSING POLYMERASE CHAIN REACTION
por: GUALDA, Kézia Peres, et al.
Publicado: (2015)

The Pentavalent Antimony Compounds in Tropical Medicine
por: Schmidt, Hans
Publicado: (1928)

AMERICAN CUTANEOUS LEISHMANIASIS WITH UNUSUAL CLINICAL PRESENTATION AND RESPONSE TO TREATMENT
por: FERNANDES, Andrea Claudia Bekner Silva, et al.
Publicado: (2016)

Pentavalent Antimonials: New Perspectives for Old Drugs
por: Frézard, Frédéric, et al.
Publicado: (2009)

Cutaneous leishmaniasis with atypical clinical manifestations: Case report
por: Neitzke-Abreu, Herintha Coeto, et al.
Publicado: (2014)

Mixed Antimony(V) Complexes with Different Sugars to Modulate the Oral Bioavailability of Pentavalent Antimonial Drugs
por: Ferreira, Weverson A., et al.
Publicado: (2014)

Detection of DNA from Leishmania (Viannia): Accuracy of Polymerase Chain Reaction for the Diagnosis of Cutaneous Leishmaniasis
por: Neitzke-Abreu, Herintha Coeto, et al.
Publicado: (2013)

New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony
por: Shin, Ji Yeon, et al.
Publicado: (2013)

EVOLUTION OF AMERICAN TEGUMENTARY LEISHMANIASIS CASES REPORTED IN PARANÁ STATE, BRAZIL
por: ALCÂNTARA, Léia Regina de Souza, et al.
Publicado: (2016)

Reactions Following the Administration of the Pentavalent Compounds of Antimony: An Analysis of Cases Reported by Several Correspondents
por: Napier, L. Everard
Publicado: (1926)

Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review
por: Brito, Nayara Castelano, et al.
Publicado: (2017)

Assessment of Immune and Clinical Response in Patients with Mucosal Leishmaniasis Treated with Pentavalent Antimony and Pentoxifylline
por: Cincura, Carolina, et al.
Publicado: (2022)

Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial
por: Oliveira, Rodrigo A, et al.
Publicado: (2012)

In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate
por: Carrió, Jaume, et al.
Publicado: (2002)

Leukocyte Behavior in Mesenteric Microcirculation upon Experimental By Leishmania Spp. in BALB/c Mice
por: Neitzke-Abreu, Herintha Coeto, et al.
Publicado: (2021)

American tegumentary leishmaniasis: severe side effects of pentavalent antimonial in a patient with chronic renal failure
por: Marques, Sílvio Alencar, et al.
Publicado: (2019)

A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis
por: Rodrigues, Bruna Côrtes, et al.
Publicado: (2020)

Environmental and Animal Characteristics as Factors Associated with American Cutaneous Leishmaniasis in Rural Locations with Presence of Dogs, Brazil
por: Membrive, Norberto Assis, et al.
Publicado: (2012)

DETECTION OF Leishmania (Viannia) IN Nyssomyia neivai AND Nyssomyia whitmani BY MULTIPLEX POLYMERASE CHAIN REACTION, IN SOUTHERN BRAZIL
por: Neitzke-Abreu, Herintha Coeto, et al.
Publicado: (2014)

Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis
por: Goyonlo, Vahid Mashayekhi, et al.
Publicado: (2019)

First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony
por: Miranda-Verastegui, Cesar, et al.
Publicado: (2009)

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis
por: Martins, Sofia Sales, et al.
Publicado: (2021)

American tegumentary leishmaniasis: diagnostic and treatment challenges in a clinical case
por: Oyama, Jully, et al.
Publicado: (2018)

In Vitro Reduced Susceptibility to Pentavalent Antimonials of a Leishmania infantum Isolate from a Human Cutaneous Leishmaniasis Case in Central Italy
por: Diotallevi, Aurora, et al.
Publicado: (2021)

The Extraordinary Case of a Woman with a 30-Year-Long Diffuse Leishmaniasis Cured with One Single Ampoule of Intranasal Pentavalent Antimoniate
por: Gonçalves, Sheila V. C. B., et al.
Publicado: (2023)

CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis
por: Thacker, Seth G, et al.
Publicado: (2020)

“Cheaper and better”: Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia
por: Eid Rodríguez, Daniel, et al.
Publicado: (2019)

Editorial: Cutaneous Leishmaniasis: Exploring Pathogenesis and Immunomodulatory Approaches
por: Pavanelli, Wander Rogério, et al.
Publicado: (2022)

Interventions for American Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review Update
por: Reveiz, Ludovic, et al.
Publicado: (2013)

Photoluminescence of Pentavalent Uranyl Amide Complexes
por: Ortu, Fabrizio, et al.
Publicado: (2021)

Catalyst control over pentavalent stereocentres
por: Budeev, Anton, et al.
Publicado: (2023)

Effect of Recycling Protocol on Mechanical Strength of Used Mini-Implants
por: Estelita, Sérgio, et al.
Publicado: (2014)

Tetra- versus Pentavalent Inhibitors of Cholera Toxin**
por: Fu, Ou, et al.
Publicado: (2015)

Immunogenicity and Complications of the Pentavalent Vaccine in Iranian Children
por: Ekrami Noghabi, Mina, et al.
Publicado: (2021)

Persistence of the Isotopic Signature of Pentavalent Uranium in Magnetite
por: Pan, Zezhen, et al.
Publicado: (2022)

Calophyllum brasiliense Modulates the Immune Response and Promotes Leishmania amazonensis Intracellular Death
por: Domeneghetti, L., et al.
Publicado: (2018)

Cost effectiveness of a pentavalent rotavirus vaccine in Oman
por: Al Awaidy, Salah Thabit, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t8qd2gligqpv2rutt623ehi0ud